What do proteomics have to do with cancer survival?
David Agus at TEDMED 2010 (3)Through a heartwarming story, David Agus discusses how doctors need to report the positives of new drugs and treatments to the medical community so we can help each other take steps towards curing terminal diseases.
David Agus at TEDMED 2010 (1)David Agus shows how when proscribing treatment, doctors and government guidelines need to view the body as a network and not a series of isolated nodes.
David Agus at TEDMED 2010 (2)In talking about HIV in Africa, David Agus calls on scientists who are working on curing diseases to spend more time outside of the lab and see first-hand how societies interact with these diseases.
IN A NUTSHELL:
One of the world’s leading cancer doctors, David Agus, will show that cancer isn't a disease, it's a process, a lifelong dynamic balance that goes on in all of us, the "sick" and "healthy" alike.
Dr. David B. Agus is a professor of medicine and engineering at the University of Southern California Keck School of Medicine and Viterbi School of Engineering and heads USC’s Westside Cancer Center and the Center for Applied Molecular Medicine. He is one of the world’s leading cancer doctors, and the co-founder of two pioneering personalized medicine companies, Navigenics and Applied Proteomics. Dr. Agus is an international leader in new technologies and approaches for personalized healthcare and chairs the Global Agenda Council on Genetics for the World Economic Forum. He has received numerous awards, including the 2009 Geoffrey Beene Foundation’s Rockstar of Science Award. Dr. Agus’ latest book, “The End of Illness”, was published in January, 2012 by Simon & Schuster and is a New York Times #1 best seller and was also the subject of a PBS series entitled “The End of Illness with Dr David Agus.”